Browse Pet Safety Reports
1,329,678 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 1,329,678 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product — widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 1,329,678 FDA veterinary adverse event reports.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Nov 8, 2025 | Dog | Boxer (German Boxer) | Pyrantel Pamoate;Sarolaner | Head tremor | Recovered/Normal |
| Nov 8, 2025 | Dog | Spaniel - Cocker American | Imidocloprid, Moxidectin | Allergic reaction; Whining; Agitation; Biting - pruritus (see also Behavioura... | Recovered/Normal |
| Nov 7, 2025 | Dog | Pit Bull | Fluralaner 13.64% 12-Week Chew | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Nov 7, 2025 | Dog | Cattle Dog - Australian (bl... | Afoxolaner 75Mg / Moxidectin 360Mcg /... | Lack of efficacy (endoparasite) - heartworm | Ongoing |
| Nov 7, 2025 | Dog | Sheepdog - Old English (Bob... | Fluralaner Powder For Inj Susp | Injection site pain; Injection site tenderness; Lethargy (see also Central ne... | Outcome Unknown |
| Nov 7, 2025 | Dog | Retriever - Labrador | Fluralaner 13.64% 12-Week Chew | Lethargy (see also Central nervous system depression in Neurological); Anorexia | Ongoing |
| Nov 7, 2025 | Cat | Domestic Shorthair | Sirolimus | Elevated gamma-glutamyl transferase (GGT) | Outcome Unknown |
| Nov 7, 2025 | — | Unknown | Enrofloxacin | Defect Unknown/Not Specified | — |
| Nov 7, 2025 | Cat | Snowshoe | Eprinomectin; Praziquantel; Esafoxolaner | Drooling; Head twitching; Application site hair loss; Spinal pain NOS; Stress... | Recovered/Normal |
| Nov 7, 2025 | Cat | Domestic Longhair | Nitenpyram | Not drinking; Lethargy (see also Central nervous system depression in Neurolo... | Outcome Unknown |
| Nov 7, 2025 | Dog | Hound - Basset, Retriever -... | Moxidectin | Not eating; Unable to walk; Immune mediated haemolytic anaemia; Elevated live... | Euthanized |
| Nov 7, 2025 | Horse | Horse (unknown) | Monensin Sodium | Death; Necropsy performed; Cardiac disorder NOS; Accidental exposure | Died |
| Nov 7, 2025 | Cat | Maine Coon | Frunevetmab | Partial lack of efficacy | Ongoing |
| Nov 7, 2025 | Dog | Crossbred Canine/dog | Ivermectin; Pyrantel | Lack of efficacy (endoparasite) - heartworm | Ongoing |
| Nov 7, 2025 | Dog | Collie - Border | Ivermectin; Pyrantel As Pamoate Salt | Lack of efficacy (endoparasite) - heartworm | Ongoing |
| Nov 7, 2025 | Dog | Chihuahua | Nitenpyram | Lack of efficacy (ectoparasite) - flea | Outcome Unknown |
| Nov 7, 2025 | Dog | Schnauzer (unspecified) | Ivermectin; Pyrantel As Pamoate Salt | Lack of efficacy (endoparasite) - hookworm | Ongoing |
| Nov 7, 2025 | Dog | Retriever - Golden, Poodle ... | Afoxolaner | Lack of efficacy (bacteria) - Anaplasma; Lack of efficacy (bacteria) - Ehrlichia | Outcome Unknown |
| Nov 7, 2025 | Dog | Retriever - Labrador | Ivermectin; Pyrantel As Pamoate Salt | Lack of efficacy (endoparasite) - hookworm; Lack of efficacy (protozoa) - Coc... | Ongoing |
| Nov 7, 2025 | Cat | Domestic Shorthair | Nitenpyram | Lack of efficacy (ectoparasite) - flea | Outcome Unknown |
| Nov 7, 2025 | Cat | Russian | Velagliflozin Proline Monohydrate | Inappropriate urination; Diarrhoea; Ketosis; Elevated blood urea nitrogen (BU... | Outcome Unknown |
| Nov 7, 2025 | Cat | Domestic Shorthair | Nitenpyram | Lack of efficacy (ectoparasite) - flea | Outcome Unknown |
| Nov 7, 2025 | Cat | Ragdoll | Mirtazapine | Application site thickening; Application site inflammation; Decreased appetit... | Outcome Unknown |
| Nov 7, 2025 | Cat | Domestic Mediumhair | Velagliflozin Proline Monohydrate | Soft stool; Lack of efficacy - NOS; Ketosis | Outcome Unknown |
| Nov 7, 2025 | Dog | Dog (unknown) | Afoxolaner | Lethargy (see also Central nervous system depression in Neurological); Unable... | Died |
| Nov 7, 2025 | Dog | Mastiff (unspecified) | Fluralaner Powder For Inj Susp | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Nov 7, 2025 | Cat | Domestic Shorthair | Cyclosporine | Lethargy (see also Central nervous system depression in Neurological); Anorex... | Ongoing |
| Nov 7, 2025 | Dog | Dog (unknown) | Bedinvetmab | Death | Died |
| Nov 7, 2025 | Dog | Retriever - Golden, Poodle ... | Fluralaner 13.64% 12-Week Chew | Limping; Lameness; Luxation/subluxation; Bone and joint disorder NOS; Footpad... | Ongoing |
| Nov 7, 2025 | Dog | Shih Tzu, Chihuahua, Poodle... | Lotilaner,Moxidectin,Praziquantel,Pyr... | Increased drinking; Decreased appetite; Frequent urination; Weight loss | Ongoing |
| Nov 7, 2025 | Cat | Domestic Shorthair | Frunevetmab | Vascular disorder NOS (see also endocarditis); Falling; Inappropriate urinati... | Ongoing |
| Nov 7, 2025 | Dog | Borzoi, Whippet | Fluralaner 13.64% 12-Week Chew | Lack of efficacy (ectoparasite) - tick NOS; Administration error NOS | Ongoing |
| Nov 7, 2025 | Dog | Poodle - Standard | Moxidectin | Immediate pain upon injection; Vocalisation; Vomiting; Bloody diarrhoea; Not ... | Ongoing |
| Nov 7, 2025 | Dog | Poodle (unspecified), Dalma... | Pyrantel Pamoate;Sarolaner | Lack of efficacy (bacteria) - Borrelia; Lack of efficacy (bacteria) - Anaplas... | Ongoing |
| Nov 7, 2025 | Dog | Terrier - Yorkshire | Fluralaner 13.64% 12-Week Chew | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Nov 7, 2025 | Cat | Domestic Shorthair | Molidustat Sodium | Pica NOS; Behavioural disorder NOS; Anorexia | Ongoing |
| Nov 7, 2025 | Dog | Retriever - Labrador | Bedinvetmab | Vestibular disorder NOS | Ongoing |
| Nov 7, 2025 | Cattle | Mixed (Cattle) | Danofloxacin Mesylate | Residues in meat/offal | Outcome Unknown |
| Nov 7, 2025 | Dog | Chihuahua, Dachshund (unspe... | Lotilaner,Moxidectin,Praziquantel,Pyr... | Neurological signs NOS; Abnormal posture NOS; Lethargy (see also Central nerv... | Recovered/Normal |
| Nov 7, 2025 | Dog | Coonhound (unspecified), Do... | Ilunocitinib | Diarrhoea | Recovered/Normal |
| Nov 7, 2025 | Dog | Retriever - Golden | Bedinvetmab | Proteinuria | Ongoing |
| Nov 7, 2025 | Dog | Retriever - Golden | Afoxolaner | Lack of efficacy (bacteria) - Ehrlichia | Outcome Unknown |
| Nov 7, 2025 | Dog | Crossbred Canine/dog | Afoxolaner 37.5Mg / Moxidectin 180Mcg... | Lack of efficacy (endoparasite) - roundworm NOS; Lack of efficacy (protozoa) ... | Ongoing |
| Nov 7, 2025 | Dog | Shiba Inu, Dog (unknown) | Bedinvetmab | Tremor; Fear/fearful | Ongoing |
| Nov 7, 2025 | Dog | Crossbred Canine/dog, Malte... | Fluralaner Powder For Inj Susp | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Nov 7, 2025 | Cat | Domestic Mediumhair | Fluralaner Spot-On Solution | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Nov 7, 2025 | Dog | Retriever - Labrador | Pyrantel Pamoate;Sarolaner | Anxiety; Restlessness; Uncomfortable; Behavioural disorder NOS | Outcome Unknown |
| Nov 7, 2025 | Cat | Crossbred Feline/cat | Frunevetmab | Dental disease; Gingivitis; Stomatitis; Elevated globulins | Ongoing |
| Nov 7, 2025 | Dog | Retriever - Labrador | Afoxolaner 150Mg / Moxidectin 720Mcg ... | Lack of efficacy (endoparasite) - hookworm | Outcome Unknown |
| Nov 7, 2025 | Dog | Terrier - Tibetan | Lotilaner,Moxidectin,Praziquantel,Pyr... | Lethargy (see also Central nervous system depression in Neurological); Elevat... | Ongoing |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe — difficulty breathing, seizures, collapse, or severe swelling — seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.